Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy US biotech Halda Therapeutics and ...

BMS and J&J's Librexia AF study is also comparing milvexian to Eliquis to see if it can prevent stroke and other clotting ...

AbbVie has turned to award-winning, Oscar-nominated director Dominic Gill to help it highlight the lives of people living ...

The announcement takes the total raised by Sofinnova Partners in the last year to €1.5 billion, and comes shortly after Anglo ...

Shares in Sarepta reversed some of their recent declines after the FDA added a warning label to its Duchenne muscular ...

A 2024 survey by the American Medical Association showed that physician usage of AI jumped 78% in a single year, which tells ...

In a statement, Avadel acknowledged that it had received the Lundbeck bid and that its board of directors had "determined in ...

MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a ...

On World Diabetes Day, Sanofi is celebrating an approval recommendation in the EU for Teizeild, a first-in-class drug ...

Alkermes already has positive results for alixorexton in NT1 from the phase 2 Vibrance-1, while Takeda is developing another ...

The $6.7 billion merger brought together two companies that had been forced to file for bankruptcy protection due to opioid ...